AI Revolution in Healthcare

AI drug development reduces time/cost by 70%; first AI-drug approval expected before 2028. BMS-Nvidia AI factory, HHS Genesis Mission, OpenAI safety concerns, AI improves cardiac amyloidosis detection. Federal agencies using LLMs as research co-pilots. Pathos AI licensing deals and clinical trial data analytics signal growing AI integration. New AI-driven blood test detects hidden heart risks up to 15 years early (multiomics approach).